Download the article in PDF format *** This article explores the recent reclassification of aspartame, a widely used artificial sweetener, by the World Health Organization (WHO) as "Possibly Carcinogenic to Humans." The move has stirred varying responses from regulatory bodies, companies, and media outlets, highlighting the complexities that consumers face in discerning fact from opinion … Continue reading Aspartame Debate: Are Economic Interests Clouding the Truth?
Tag: safety
The Cost of Manipulation: The Irresponsible Abuse of Technological Opacity in the Pharmaceutical Industry
Download the article in PDF format *** This article explores the risks associated with the irresponsible use of technology in the pharmaceutical industry, including scientific manipulation in drug trials, scientific misrepresentation through ghost-written publications, and abuse of technology through the misrepresentation of risks. The article highlights the negative impacts of these practices on patients, healthcare … Continue reading The Cost of Manipulation: The Irresponsible Abuse of Technological Opacity in the Pharmaceutical Industry
Dr. Yasmine Motarjemi – Whistleblowing, Labour Law, corporate culture and risk management in Multinational Enterprises (video)
On the 14th of October 2020, Dr. Yasmine Motarjemi (whistleblower and former Head of Food Safety at Nestlé) gave her presentation during the first seminar of the Corporate Social Responsibility and Business Ethics Blog’s End-of-Year Seminar Series 2020 entitled “CSR, Whistleblowing and Human Rights” and organized by Dr. Costantino Grasso, Dr. Dawn Carpenter, and Dr. … Continue reading Dr. Yasmine Motarjemi – Whistleblowing, Labour Law, corporate culture and risk management in Multinational Enterprises (video)
How to Enhance Social Responsibility with Seemingly Irresponsible Behavior
*** Download the article as a PDF *** Introduction To be socially responsible, organizations must deliver value for investors and society. Yet despite the growth in corporate social responsibility (CSR), many major challenges such as tropical deforestation and climate change are greater today than when the CSR movement began accelerating in the 1990s. The problem … Continue reading How to Enhance Social Responsibility with Seemingly Irresponsible Behavior
Death from the inside: An analysis of the murderous business strategy of Takata corporation
* The editorial board would like to give a special thank you to Takata's whistle-blower - Mark Lillie - for checking for inaccuracies in this post * Takata Kabushiki Gaisha (Takata Corp) was a company established in 1933 by the Takada family which manufactured automotive parts such as seatbelts, airbag systems, child restraint systems, and … Continue reading Death from the inside: An analysis of the murderous business strategy of Takata corporation
Challenges and advantages of robotic nursing care: a social and ethical analysis
Robotics is an interdisciplinary branch of engineering and science that includes, inter alia, mechanical engineering, electrical engineering, and computer science. This emerging field of technological advancement deals with the connection of perception to action and where that connection is to be "intelligent," then artificial intelligence (AI) plays a fundamental role in robotics. Robotic technology has … Continue reading Challenges and advantages of robotic nursing care: a social and ethical analysis
Understaffing and its threats to patient safety: irresponsible behavior in pharmacy chains
Boots Pharmacy, part of the largest pharmacy chain in Europe and the United States, has once again found itself in the spotlight for yet another dispensing error. On the 14th of December, the incorrect medication was dispensed to a customer at a Basingstoke, Hampshire branch (United Kingdom). The pharmacist on duty filled the patient’s prescription for … Continue reading Understaffing and its threats to patient safety: irresponsible behavior in pharmacy chains
Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry
Thalidomide is a synthetic drug developed in 1954 by German pharmaceutical company, Chemie Grünenthal, for use as a sedative in the treatment of insomnia and anxiety. Because of its purported atoxic nature, the use of this “wonder drug” quickly became widespread all over Europe. It was initially used to treat conditions like colds, headaches, and … Continue reading Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry